Cargando…
Efficacy of a novel patient-focused intervention aimed at increasing adherence to guideline-based preventive measures in asplenic patients: the PrePSS trial
PURPOSE: To determine whether a novel intervention improves the adherence to guideline-based preventive measures in asplenic patients at risk of post-splenectomy sepsis (PSS). METHODS: We used a prospective controlled, two-armed historical control group design to compare a novel, health action proce...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665246/ https://www.ncbi.nlm.nih.gov/pubmed/37653288 http://dx.doi.org/10.1007/s15010-023-02088-7 |
_version_ | 1785138786863153152 |
---|---|
author | Camp, Johannes Bayrhuber, Marianne Anka, Natascha Heine, Valerie Glattacker, Manuela Farin-Glattacker, Erik Rieg, Siegbert |
author_facet | Camp, Johannes Bayrhuber, Marianne Anka, Natascha Heine, Valerie Glattacker, Manuela Farin-Glattacker, Erik Rieg, Siegbert |
author_sort | Camp, Johannes |
collection | PubMed |
description | PURPOSE: To determine whether a novel intervention improves the adherence to guideline-based preventive measures in asplenic patients at risk of post-splenectomy sepsis (PSS). METHODS: We used a prospective controlled, two-armed historical control group design to compare a novel, health action process approach (HAPA)-based telephonic intervention involving both patients and their general practitioners to usual care. Eligible patients were identified in cooperation with the insurance provider AOK Baden-Wuerttemberg, Germany. Patients with anatomic asplenia (n = 106) were prospectively enrolled and compared to a historical control group (n = 113). Comparisons were done using a propensity-score-based overlap-weighting model. Adherence to preventive measures was quantified by the study-specific ‘Preventing PSS score’ (PrePSS score) which includes pneumococcal and meningococcal vaccination status, the availability of a stand-by antibiotic and a medical alert card. RESULTS: At six months after the intervention, we estimated an effect of 3.96 (95% CI 3.68–4.24) points on the PrePSS score scale (range 0–10) with mean PrePSS scores of 3.73 and 7.70 in control and intervention group, respectively. Substantial improvement was seen in all subcategories of the PrePSS score with the highest absolute gains in the availability of stand-by antibiotics. We graded the degree of participation by the general practitioner (no contact, short contact, full intervention) and noted that the observed effect was only marginally influenced by the degree of physician participation. CONCLUSIONS: Patients who had received the intervention exhibited a significantly higher adherence to guideline-based preventive measures compared to the control group. These data suggest that widespread adoption of this pragmatic intervention may improve management of asplenic patients. Health insurance provider-initiated identification of at-risk patients combined with a patient-focused intervention may serve as a blueprint for a wide range of other preventive efforts leading to patient empowerment and ultimately to better adherence to standards of care. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-023-02088-7. |
format | Online Article Text |
id | pubmed-10665246 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-106652462023-09-01 Efficacy of a novel patient-focused intervention aimed at increasing adherence to guideline-based preventive measures in asplenic patients: the PrePSS trial Camp, Johannes Bayrhuber, Marianne Anka, Natascha Heine, Valerie Glattacker, Manuela Farin-Glattacker, Erik Rieg, Siegbert Infection Research PURPOSE: To determine whether a novel intervention improves the adherence to guideline-based preventive measures in asplenic patients at risk of post-splenectomy sepsis (PSS). METHODS: We used a prospective controlled, two-armed historical control group design to compare a novel, health action process approach (HAPA)-based telephonic intervention involving both patients and their general practitioners to usual care. Eligible patients were identified in cooperation with the insurance provider AOK Baden-Wuerttemberg, Germany. Patients with anatomic asplenia (n = 106) were prospectively enrolled and compared to a historical control group (n = 113). Comparisons were done using a propensity-score-based overlap-weighting model. Adherence to preventive measures was quantified by the study-specific ‘Preventing PSS score’ (PrePSS score) which includes pneumococcal and meningococcal vaccination status, the availability of a stand-by antibiotic and a medical alert card. RESULTS: At six months after the intervention, we estimated an effect of 3.96 (95% CI 3.68–4.24) points on the PrePSS score scale (range 0–10) with mean PrePSS scores of 3.73 and 7.70 in control and intervention group, respectively. Substantial improvement was seen in all subcategories of the PrePSS score with the highest absolute gains in the availability of stand-by antibiotics. We graded the degree of participation by the general practitioner (no contact, short contact, full intervention) and noted that the observed effect was only marginally influenced by the degree of physician participation. CONCLUSIONS: Patients who had received the intervention exhibited a significantly higher adherence to guideline-based preventive measures compared to the control group. These data suggest that widespread adoption of this pragmatic intervention may improve management of asplenic patients. Health insurance provider-initiated identification of at-risk patients combined with a patient-focused intervention may serve as a blueprint for a wide range of other preventive efforts leading to patient empowerment and ultimately to better adherence to standards of care. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-023-02088-7. Springer Berlin Heidelberg 2023-09-01 2023 /pmc/articles/PMC10665246/ /pubmed/37653288 http://dx.doi.org/10.1007/s15010-023-02088-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Camp, Johannes Bayrhuber, Marianne Anka, Natascha Heine, Valerie Glattacker, Manuela Farin-Glattacker, Erik Rieg, Siegbert Efficacy of a novel patient-focused intervention aimed at increasing adherence to guideline-based preventive measures in asplenic patients: the PrePSS trial |
title | Efficacy of a novel patient-focused intervention aimed at increasing adherence to guideline-based preventive measures in asplenic patients: the PrePSS trial |
title_full | Efficacy of a novel patient-focused intervention aimed at increasing adherence to guideline-based preventive measures in asplenic patients: the PrePSS trial |
title_fullStr | Efficacy of a novel patient-focused intervention aimed at increasing adherence to guideline-based preventive measures in asplenic patients: the PrePSS trial |
title_full_unstemmed | Efficacy of a novel patient-focused intervention aimed at increasing adherence to guideline-based preventive measures in asplenic patients: the PrePSS trial |
title_short | Efficacy of a novel patient-focused intervention aimed at increasing adherence to guideline-based preventive measures in asplenic patients: the PrePSS trial |
title_sort | efficacy of a novel patient-focused intervention aimed at increasing adherence to guideline-based preventive measures in asplenic patients: the prepss trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665246/ https://www.ncbi.nlm.nih.gov/pubmed/37653288 http://dx.doi.org/10.1007/s15010-023-02088-7 |
work_keys_str_mv | AT campjohannes efficacyofanovelpatientfocusedinterventionaimedatincreasingadherencetoguidelinebasedpreventivemeasuresinasplenicpatientstheprepsstrial AT bayrhubermarianne efficacyofanovelpatientfocusedinterventionaimedatincreasingadherencetoguidelinebasedpreventivemeasuresinasplenicpatientstheprepsstrial AT ankanatascha efficacyofanovelpatientfocusedinterventionaimedatincreasingadherencetoguidelinebasedpreventivemeasuresinasplenicpatientstheprepsstrial AT heinevalerie efficacyofanovelpatientfocusedinterventionaimedatincreasingadherencetoguidelinebasedpreventivemeasuresinasplenicpatientstheprepsstrial AT glattackermanuela efficacyofanovelpatientfocusedinterventionaimedatincreasingadherencetoguidelinebasedpreventivemeasuresinasplenicpatientstheprepsstrial AT faringlattackererik efficacyofanovelpatientfocusedinterventionaimedatincreasingadherencetoguidelinebasedpreventivemeasuresinasplenicpatientstheprepsstrial AT riegsiegbert efficacyofanovelpatientfocusedinterventionaimedatincreasingadherencetoguidelinebasedpreventivemeasuresinasplenicpatientstheprepsstrial |